𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impairment of the supervisory attentional system in early untreated patients with Parkinson’s disease

✍ Scribed by K. Dujardin; Jean François Degreef; Pascal Rogelet; L. Defebvre; Alain Destee

Publisher
Springer
Year
1999
Tongue
English
Weight
52 KB
Volume
246
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for Parkinson's disease and
Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease
✍ Andrew Siderowf; Danna Jennings; James Connolly; Richard L. Doty; Kenneth Marek; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Abstract Our objective was to assess the association between risk factors for Parkinson's disease (PD) and abnormal olfaction in first‐degree relatives of patients with PD. Factors including lower cigarette smoking and lower caffeine consumption have been associated with increased risk of PD. Id

Interference of rhythmic constraint on g
Interference of rhythmic constraint on gait in healthy subjects and patients with early parkinson's disease: Evidence for impaired locomotor pattern generation in early Parkinson's disease
✍ Georg Ebersbach; Michaela Heijmenberg; Leonie Kindermann; Thomas Trottenberg; Jö 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Patients in the early stages of Parkinson's disease have been shown to walk slower with smaller steps, resembling the gait of normal elderly subjects, but specific disorders of dynamic equilibrium or rhythmic gait patterning have not yet been identified. In the present study, gait control in 22 heal

Rasagiline improves quality of life in p
Rasagiline improves quality of life in patients with early Parkinson's disease
✍ Kevin M. Biglan; Steven Schwid; Shirley Eberly; Karen Blindauer; Stanley Fahn; T 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 1 views

The objective of this study was to determine the effects of rasagiline as monotherapy on quality of life (QOL) in patients with early Parkinson's disease (PD). Rasagiline, a potent, second-generation, irreversible, selective monoamine oxidase B inhibitor improves PD symptoms in patients with early P

A controlled trial of piracetam in intel
A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease
✍ Mary Sano; Yaakov Stern; Karen Marder; Richard Mayeux 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 1 views

## Abstract Twenty patients with Parkinson's disease and marked intellectual impairment or dementia participated in a double‐blind placebo controlled trial of the nootropic, piracetam. A standardized neurological examination, a neuropsychological test battery, and a functional scale, The Sickness I